# S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer

> **NCT01674140** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **SWOG Cancer Research Network** · enrollment: 1939 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** anastrozole
- **DRUG:** everolimus
- **DRUG:** exemestane
- **DRUG:** goserelin acetate
- **DRUG:** letrozole
- **DRUG:** leuprolide acetate
- **DRUG:** tamoxifen citrate
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT01674140
- **Lead sponsor:** SWOG Cancer Research Network
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2013-09-12
- **Primary completion:** 2022-12-01
- **Final completion:** 2030-01
- **Target enrollment:** 1939 (ACTUAL)
- **Last updated:** 2026-02-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01674140

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01674140, "S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01674140. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*